BioSpace News Archive

EnlivenHealth™ Launches CareScheduler Solution to Enable Pharmacies to Provide Hands-Free Scheduling, Consent and Registry Reporting for COVID-19 Vaccine, Reducing Infection Risk for Patients and Staff

BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will today present an updated clinical & translational analysis from its Phase II bemcentinib and pembrolizumab combination study (BGBC008) in advanced non-small cell lung cancer (NSCLC),

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today announced that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 6th Annual Israel Conference.

MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide registry of hypertrophic cardiomyopathy (HCM), which leverages the ACC’s PINNACLE Cardiovascular Registry operated by Veradigm®, an Allscripts (NASDAQ: MDRX), business unit. The registry will support MyoKardia’s post-marketing safety and effectiveness study (DISCOVER-HCM) of mavacamten, an investigational the

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Stifel Virtual Healthcare Conference on November 17 and participate in the A.G.P. Virtual Healthcare Symposium on November 19.

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the Virtual Fall Investor Summit to be held virtually on November 16-18, 2020. Leonard Osser, Interim Chief Executive Officer, is scheduled to present on Wednesday, November 18 th at 9:30 a.m., Eastern Time.

NYU Grossman School of Medicine is among the centers enrolling participants in a randomized phase 3 clinical trial to determine the safety and efficacy of the COVID-19 vaccine candidate developed by the pharmaceutical company AstraZeneca.

ColdQuanta, the quantum atomics company, previewed its quantum computer technology, built on its Quantum Core™.

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, announced that its Special Meeting of Stockholders, scheduled for October 22, 2020 and adjourned to November 11, 2020, was convened and adjourned without any business being conducted due to the fact that a quorum was not achieved on the proposals to be approved.

Surgalign Holdings, Inc. announced it plans to release financial results from the third quarter 2020 on Wednesday, November 11, 2020, after the market closes.